藥物成份

共有 21677 個藥物成份

Sodium Hyaluronate.....0.100 g.;\nSodium Chloride.....0.620 g.;\nBoric Acid.....0.500 g.;\nDisodium Edetate.....0.100 g.;\nBorax.....0.091 g.;\nPurified Water.....100 ml.\n以下空白

• 關聯藥證數量: 1

Sodium Hyaluronate.....1.5mg;\nPotassium Chloride.....3.0mg;\nSodium Chloride.....5.5mg;\nSodium Phosphate Dibasic Dodecahydrate.....4.0mg;\nSodium Phosphate Monobasic Dihydrate.....0.6mg\n以下空白

• 關聯藥證數量: 1

Sodium Hyaluronate.....10mg;\nNa2HPO4．12H2O.....1.344mg;\nNaH2PO4．2H2O.....0.04mg;\nNac1.....8.5mg;\nWater for Injection\n以下空白

• 關聯藥證數量: 1

Sodium Hyaluronate.....10mg\nSodium Chloride.....8.5mg\nDisodium Hydrogen Phosphate, Sodium Dihydrogen Phosphate, 和適量的注射用水加至1ml。\n以下空白

• 關聯藥證數量: 1

Sodium Hyaluronate.....25.5mg\nPhosphate buffer Solution.....1.0ml\n以下空白

• 關聯藥證數量: 1

Sodium Hyaluronate………10mg\nSodium chloride……………8.5mg\nSodium monohydrogenphosphate-12H2O………0.6mg\nSodium dihydrogenphosphate-2 H2O…………0.05mg\nWater for injection add to………………1.0ml\n以下空白

• 關聯藥證數量: 1

Sodium Hydrogen Carbonate (Sodium Bicarbonate) contains not less than 99.0% and not more than 100.5% of NaHCO3, calculated on the dried substance.

• 關聯藥證數量: 1

Sodium Hydroxide：0.188 mol/L Picric Acid：0.05 mol/L

• 關聯藥證數量: 1

Sodium L-asparatate , Diarylimidazole leuco dye.

• 關聯藥證數量: 1

Sodium Lauryl Sulfate 1.7g/L

• 關聯藥證數量: 1

Sodium Lauryl Sulfate < 3 g/L

• 關聯藥證數量: 1

Sodium Nitrite…………….20%\nSodium Azide……………..20%\nSodium Deoxycholate…….40%\nNon-reactive Ingredients….20%\n

• 關聯藥證數量: 1

Sodium Phosphate, Dibasic <0.3%Potassium Phosphate, Monobasic <0.05%Disodium EDTA, Dihydrate <0.03%Sodium Chloride <1.0%Potassium Chloride <0.05%Surfactant <0.002%

• 關聯藥證數量: 1

Sodium Phosphate, Dibasic <0.3%\nPotassium Phosphate, Monobasic <0.05%\nDisodium DETA, Dihydrate <0.03%\nSodium Chloride <1.0%\nPotassium Chloride <0.05%\nSurfactant <0.002%\nPreservatives <0.04

• 關聯藥證數量: 1

Sodium Picosulfate contains not less than 98.5% and not more than 100.5% of C18H13NNa2O8S2‧H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sodium Selenite Pentahydrate (Na2SeO3‧5H2O) contains 98.5~101.5% (Dried basis)

• 關聯藥證數量: 1

Sodium Sulfate 12.85g/LSodium Chloride 0.6g/LTetracaine HCL 0.02g/LImidazole 3.5g/L

• 關聯藥證數量: 1

Sodium Sulfate Anhydrous Sodium Chloride Anti-Microbial Agent Buffer Stabilizer <1.0% <0.5%<0.1%<0.1%<0.1%

• 關聯藥證數量: 1

Sodium Sulfate Anhydrous Sodium Chloride Anti-Microbial Agent Polyoxyethylene Ether <1.50% <0.60%<0.10%<0.25%

• 關聯藥證數量: 1

Sodium Valproate contains not less than 98.5% and not more than 101.0% of C8H15NaO2, calculated on the dried substance.

• 關聯藥證數量: 1

Sodium Zirconium Cyclosilicate

• 關聯藥證數量: 1

Sodium Zirconium Cyclosilicate

• 關聯藥證數量: 1

Sodium acetate anhydrous contains not less than 99.0% and not more than 101.0% of C2H3NaO2, calculated on the dried basis.

• 關聯藥證數量: 1

Sodium acetate, pH 5.9, 54.2 mmol/L\nArsenazo III, 188 μmol/L\nNon-reactive stabilizers

• 關聯藥證數量: 1

Sodium bicarbonate contains not less than 99.0 percent and more than 100.5 percent of NaHCO3, calculated on the dried basis.

• 關聯藥證數量: 1

Sodium borate

• 關聯藥證數量: 1

Sodium chloride.................................7.1mg\nSodium borate...................................0.43mg\nBoric acid..........................................4.3mg\nWater for injection add to make...........1.0ml\n以下空白

• 關聯藥證數量: 1

Sodium chloride......................76mg\nDisodium phosphate................28mg\nCatalase.................................0.1mg\nRiboflavine 5-phosphate............0.075mg\nPolyvinylpyrrolidone..................62.5mg\nHydroxyethylmethylcellulose.....2.6mg\n以下空白\n

• 關聯藥證數量: 1

Sodium chloride..........8.027%\nSyloid-244..........1.944%\nCedepal TD-403.........26.31%\nMakon OP-9.........0.357%\nSodium phosphate..........0.486% \nPhospholipid P-TC..........0.178%\nTitanium dioxide.......... 0.628%\nPurified water .........q.s. to 100%\n以下空白

• 關聯藥證數量: 1

Sodium chloride.....4.3mg;\nSodium Citrate 2H2O.....9.2mg;\nEdetate Disodium.....0.5mg;\nPolyclin (Polyquaternium-1)50%.....0.02mg;\nTween-80.....3.0mg;\nWater for injection added to......1ml\n以下空白

• 關聯藥證數量: 1

Sodium chloride.....4.5mg;\nBoric acid.....8.2mg;\nSodium borate.....0.8mg;\nEdetate disodium.....0.1mg;\nPolyhexamethylene biguanide hydrochloride solution 20%.......0.005mg;\nPolyoxyethylene polyoxypropylene block Copolymer.....10mg;\nWater for injection added to.....1ml\n以下空白

• 關聯藥證數量: 1

Sodium chloride.....7.4mg\nPotassium chloride.....1.3mg\nDisodium hydrogen phosphate anhydrous.....1.13mg\nSodium dihydrogen phosphate anhydrous.....0.3mg\nSodium hyaluronate.....0.2mg\nHydroxypropylmethylcellulose.....2.0mg\nSodium hydroxide q.s.\nHydrochloric acid q.s.\nWater q.s.\n以下空白\n

• 關聯藥證數量: 1

Sodium chloride、Potassium chloride

• 關聯藥證數量: 1

Sodium chloride、Potassium chloride.

• 關聯藥證數量: 1

Sodium citrate

• 關聯藥證數量: 1

Sodium copper chlorophyllin contains not less than 98% (on the dried basis).

• 關聯藥證數量: 1

Sodium hyaluronat

• 關聯藥證數量: 1

Sodium hyaluronate 1.8%，以下空白。

• 關聯藥證數量: 1

Sodium hyaluronate 2%，以下空白。

• 關聯藥證數量: 1

Sodium hyaluronate 30 mg/ml ，以下空白。

• 關聯藥證數量: 1

Sodium hydroxide

• 關聯藥證數量: 1

Sodium hydroxide 0.5 mol/L\nEDTA 50 μumol/L\nSubstituted Porphyrin 20 μmol/L\nStandard : prepared from a stock Lithium solution diluted in physiological saline (0.5g/L)\n

• 關聯藥證數量: 1

Sodium hydroxide 0.5 mol/L; EDTA 50 μmol/L; substituted porphyrin 15 μmol/L; preservative; detergent

• 關聯藥證數量: 1

Sodium hydroxide 0.5mol/L,EDTA 50mmol/L,Substituted Porphyrin 15mmol/L,preservative, surfactant.

• 關聯藥證數量: 1

Sodium hydroxide 120 mmol/l\nPicric acid 2.9 mmol/l\nPreservative

• 關聯藥證數量: 1

Sodium hydroxide 200 mmol/lPotassium sodium tartrate 32 mmol/lCopper sulphate 18.8 mmol/lPotassium iodide 30 mmol/l

• 關聯藥證數量: 1

Sodium hydroxide 600 mmol/L\nCopper sulfate 12 mmol/L\nSodium potassium tartrate 32 mmol/L\nPotassium iodide 30 mmol/L

• 關聯藥證數量: 1

Sodium hypochlorite(0.82 mol/L)

• 關聯藥證數量: 1

Sodium nitrite : 0.5% ; Hydrochloric acid : 0.5M ; Sulfanilic acid : 0.45% ; Hydrochloric acid : 1.09%

• 關聯藥證數量: 1

Sodium pertechnetate Tc-99m, as eluted is in Sodium Chloride 0.9% as a sterile.

• 關聯藥證數量: 1

Sodium phosphate,Sodium Chloride, potassium phosphate.

• 關聯藥證數量: 1

Sodium selenite anhydrous

• 關聯藥證數量: 1

Sodium, Bicarbonate contains not less than 99.0% OF NaHCO3.

• 關聯藥證數量: 1

Solifenacin Succinate contains 99.0% ~ 101.0% of C23H26N2O2‧C4H6O4 (dried substance).

• 關聯藥證數量: 1

Solifenacin Succinate contains NLT 98.0% and NMT 102.0% of C27H32N2O6, calculated on anhydrous substance.

• 關聯藥證數量: 1

Solifenacin Succinate contains not less than 98.0% and not more than 102.0% of C23H26N2O2‧C4H6O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Solifenacin Succinate contains not less than 99.0% and not more than 101.0% of C27H32N2O6, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Solifenacin Succinate contains not less than 99.0% and not more than 101.0% of C27H32N2O6, calculated on the dried basis.

• 關聯藥證數量: 1

Solifenacin Succinate not less than 99.0% and not more than 101.0% of C27H32N2O6, calculated on dried substance.

• 關聯藥證數量: 1

Soluble Azulene contains Sodium 1.4-dimethyl-7-isopropylazlene-3-sulfonate 98.5% up

• 關聯藥證數量: 1

Solution 1 (MUP):4-Methylumbellifery phosphate, 1.2Mm, in AMP buffer\nSolution 3 (Matrix Cell Wash):0.3M Sodium Chloride in TRIS Buffer\nSolution 4 (Line Diluent):0.1M Phosphate Buffer\nAxSYM Probe Cleaning Solution:2% Tetraethylammonium Hydroxide (TEAM)

• 關聯藥證數量: 1

Solution of salts: Na+, K+, Cl-, Li+, Ca2+ (normal, abnormal high, abnormal low)\nBuffers\nBovine albumin

• 關聯藥證數量: 1

Somatostatin contains not less than 95.0% and not more than 104.0% of C76H104N18O19S2, calculated on anhydrous and acetic acid-free substance.

• 關聯藥證數量: 1

Sorafenib Tosylate contains not less than 97.5% and not more than 102.0% of Sorafenib Tosylate (C21H16ClF3N4O3‧C7H8SO3), calculated on anhydrous basis.

• 關聯藥證數量: 1

Sorbitol

• 關聯藥證數量: 1

Sotorasib

• 關聯藥證數量: 1

Special Processing Kit: 40-300 300 x Specimen Collection Vial (10ml/vial) 300 x Plastic centrifuge tubes (15ml) 3 x Cleaning Solution (410ml/bottle) 1 x Cellular Base Solution (225ml/bottle)40-3001 300 x Specimen collection vial (10ml/vial) 3 x Cleaning Solution (410ml/bottle) 1 x Cellular Base Solution (225ml/bottle)40-100 100 x Specimen Collection Vial (10ml/vial) 100 x Plastic centrifuge tubes (15ml) 1 x Cleaning Solution (410ml/bottle) 2 x Cellular Base Solution (38ml/bottle)

• 關聯藥證數量: 1

Specific Anti-IgE ImmunoCAP: Mouse monoclonal antibodies

• 關聯藥證數量: 1

Specific Antibody-dye conjugatesBiotinylated rabbit polyclonal anti-cTnI antibodyImmobilized streptavidine

• 關聯藥證數量: 1

Specific Gravity Polyvinyl phosphate 16.0 mg\n Bromthymol blue 2.2 mg\n Methyl red 0.17 mg\npH Bromethymol blue 0.77 mg\n Methyl red 0.10 mg\nBlood 2.5-Dimethylhexane-2.5-dihydroperoxide 7.18 mg\n 3,3’,5.5’-Tetramelhylbenzidine 2.94 mg\nLeukocyte Indoxylcarbonic acid ester 0.29 mg\n Diazonium salt 0.19 mg\nNitrite p-Arsanilic acid 4.4 mg\n Hydroxy(3)-1,2,3-tetrahydrobenzo-(h)quinoline 4.1 mg\nProtein Tetrabromophenol blue 0.29 mg\n Citric acid 128.9 mg\nBilirubin 2.4-Dichlorobenzenediazonium salt 2.5 mg\n Sulfoasalicylic acid 16.9 mg\nKetone Sodium nitroprusside 12.0 mg\nGlucose Glucose oxidase (Aspergillus niger) 793 unit\n Peroxidase (Horseradish) 111 unit\n Potassium iodide 9.09 mg\nUrobilinogen 4-Methoxybenzene-diazoni-umtetrafluoroborate 0.64 mg\n\n\n

• 關聯藥證數量: 1

Specific Gravity：2.5% w/w bromthymol blue indicator；17.5% w/w buffer and non-reactive ingredients；55% poly(methyl vinyl ether/maleic anhydride)；25% sodium hydroxideBlood：4% w/w 3,3’,5,5’-tetramethylbenzidine (TMB)；6% w/w cumene hydroperoxide；90% w/w buffer and non-reactive ingredients pH：0.5% w/w methyl red sodium salt；5% w/w bromthymol blue；94.5% w/w non-reactive ingredientsProtein：0.3% w/w tetrabromophenol blue；99.7% w/w buffer and non-reactive ingredientsUrobilinogen：2.5% w/w p-diethylaminobenzaldehyde；97.5% w/w buffer and non-reactive ingredientsNitrite：4.5% w/w p-arsanilic acid；95.5% w/w non-reactive ingredients

• 關聯藥證數量: 1

Specific IgG Calibrators：\nHuman IgG in buffer Conc.: 0.02; 0.04; 0.1; 0.3; 1.0 and 2.0 mg/l, Kathon CG 0.15%

• 關聯藥證數量: 1

Specific IgG Curve Controls：\nSpecific IgG Curve Control 1 (CC-1) Human IgG in buffer, Kathon CG 0.15%\nSpecific IgG Curve Control 1 (CC-2) Human IgG in buffer, Kathon CG 0.15%

• 關聯藥證數量: 1

Specific IgG4 Calibrators：\nConc.: 1.5; 3.0; 15; 35; 150 and 300 μg/l, Kathon CG 0.15%

• 關聯藥證數量: 1

Specificity CD14\nClone 116\nHybridoma P3/NS1/ 1-AG4-1×BALB/c\nImmunogen Human adherent peripheral blood mononuclear cells\nIg Chain IgM\nSpecies Mouse\nSource Ascites fluid or conditioned medium\nPurification Gel filtration chromatography\nFluorescenc Excites at 486-509 nm/Emits at 504-541 nm\nConjugation FITC (Fluorescein isothiocyanate)\nMolar Ration FITC/Oriteub: 20-30\n

• 關聯藥證數量: 1

Specificity CD38\n FITC PE PC5\nClone T16 LS198-4-3 LS198-4-3\nImmunogen PBL (Peripheral Blood leucocytes) activated by PHA Human T cell lymphocytic line (Hut 78) Human lymphocytic line (Hut 78)\nHybridoma SP2/0 x Balb/c\nImmunoglobulin IgG1\nSpecies Mouse\nSource Ascites\nPurification Protein A affinity chromatography\nFluorochrome FITC PE PC5\nλ excitation 488 nm 488 nm 488 nm\nEmission 525 nm 575 nm 670 nm\nBuffer PBS pH 7.2 plus 2 mg / BSA and 0.1% NaN3\n

• 關聯藥證數量: 1

Specificity CD4\nClone SFCI12T4D11\nHybridoma NS/1-AG4 × BALB/c\nImmunogen Human peripheral blood T Iymphocytes\nIg Chain IgG1\nSpecies Mouse\nSource Conditioned medium\nPurification Affinity chromatography \nFluorescence Excites at 486-575 nm / Emits at 568-590 nm \nConjugation RD1 (Phycoerythrin)\nMolar Ratio RD1/Protein: 0.5-1.5\n\n

• 關聯藥證數量: 1

Specificity Non Applicable\nClone 2T8-2F5\nHybridoma NS-1×BALB/c\nImmunogen Non Applicable\nIg Chain IgG1\nSpecies Mouse\nSource Conditioned media\nPurification Affinity chromatography\nFluorescence Excites at 468-509 nm/Emits at 504-541 nm\nConjugation FITC (Fluorescein isothiocyanate)\nMolar Ration FITC Protein: 3-10\n

• 關聯藥證數量: 1

Specimen Diluent: Concentrated (10X) glycine buffered saline (pH 8.6) containing albumin and a preservative.\nCryptococcal Latex: Standardized latex particles sensitized with rabbit anti-cryptococcal globulin in glycine buffered saline containing a preservative.\nCryptococcal Antigen Positive Control: Purified capsular polysaccharide antigens containing a preservative.\nNegative Control: Normal goat serum containing a preservative.\nPronase: Lyophilized Pronase containing a presrvative.\nPronase Control: Goat anti-rabbit globulin containing a preservative.\nPronase Inhibitor: Contains an inhibitor for the Pronase.\nDisposable Ring Slides

• 關聯藥證數量: 1

Spectincomycin Hydrochloride has a potency equivalent to not less than 603ug of spectinomycin (C14H24N2O7) per mg.

• 關聯藥證數量: 1

SpermMar Test IgG：SpermMar latex particles, 0.7 ml\n SpermMar antiserum, 0.7 ml\nSpermMar Test IgA：SpermMar latex particles, 0.7 ml\n

• 關聯藥證數量: 1

Spironolactone contains 97.0% to 102.0% of C24H32O4S.(dried substance)

• 關聯藥證數量: 1

Spironolactone contains NLT 97.0% and NMT 103.0% of C24H32O4S, calculated on the dried basis.

• 關聯藥證數量: 1

Spironolactone contains not less than 97.0 percent and not more than 103.0 percent of C24H32O4S, calculated on the dried basis.

• 關聯藥證數量: 1

Spironolactone contains not less than 97.5% and not more than 102.0% of C24H32O4S calculated on the dried basis.

• 關聯藥證數量: 1

Spironolactone contains not less than 97.5% and not more than 102.0% of C24H32O4S, calculated on the dried substance.

• 關聯藥證數量: 1

Spironolactone. It contains not less than 97.0% and not more than 103.0% of C24H32O4S, calculated on the dried basis.

• 關聯藥證數量: 1

Spotechem E-Plate is a complete disposable electrode which measures Na+, K+, and Cl- simultaneously. Its reactive portion is made up of two layers: the first layer is formed by an ion selective membrane and underneath this is a silver/silver chloride layer as base electrode. On the surface of plate, there are a sample well, a reference solution well, probe-contact holes where a potential formed on each of Na+, K+, and Cl- electrodes is measured, and air bleeding holes.

• 關聯藥證數量: 1

Stabilized human or mammalian red blood cells, human, mammalian or simulated white blood cells and a platelet component in a preservative medium.

• 關聯藥證數量: 1

Stabilized human whole blood hemolysate to which cyclosporin A has been added to the appropriate levels.

• 關聯藥證數量: 1

Stabilized human whole blood to which cyclosporin A and tacrolimus have been added to the appropriate levels.

• 關聯藥證數量: 1

Stabilizing solution 18 ml x 1\nLatex solution 4 ml x 1\nLatex coated with Human gamma-globulin 4 ml/bottle.

• 關聯藥證數量: 1

Stabilizing solution: 18 mL\nLatex solution: 4 mL\nLatex coated with anti-Ferritin Polyclonal antibody: 4 mL

• 關聯藥證數量: 1

Stable - isotope amino acids, carnitine, acylcarnitines internal standards, and analytes details as stated on user’s manual.

• 關聯藥證數量: 1

Stained Salmonella Suspensions：\nStandardised smooth suspensions of killed bacteria which have been stained to facilitate reading of agglutination tests.Preserved with 0.25 % formalin and 0.01 % thiomersal.\nS.typhi Vi Suspension：\nStandardised to contain approximately 10 10 bacteria per ml and is preserved with 25 % formalin and 0.01% thiomersal.\nS.typhi Vi Standsrd Serum：\nHorse serum containing antibodies to S. typhi Vi preserved with 0.01 % thiomersal.\nFebrile Antigen Positive Control Serum：\nProduced in rabbits and preserved with 0.5% phenol.\nFebrile Antigen Negative Control Serum：\nProduced in rabbits and preserved with 0.5% phenol.

• 關聯藥證數量: 1

Standard 1: 5 ug/mL\nStandard 2: 10 ug/mL\nStandard 3: 25 ug/mL\nStandard 4: 50 ug/mL\nStandard 5: 200 ug/mL

• 關聯藥證數量: 1

Standard A-D 1; 10; 35; 150 U/mL. Standard A=Negative Control Standard B=Cut-Off Control Standard C=Weakly Positive Control Standard D=Positive Control Contains IgM antibodies against Measles, PBS, stabilizers. Enzyme Conjugate IgM Contains anti-human IgM, conjugated to peroxidase, protein-containing buffer, stabilizers. Microtiter Plate Coated with specific antigen. TMB Substrate Solution Contains TMB. TMB Stop Solution 0.5 M H2SO4 Diluent Buffer Contains PBS Buffer, BSA, <0.1% NaN3 Wash Buffer, Concentrate (10x) Contains PBS Buffer, Tween 20. Adhesive Foil For covering of Microtiter Plate during incubation. Plastic Bag Resealable. For dry storage of non-used strips.

• 關聯藥證數量: 1

Standard A-D 1;10;40; 250 U/mL. Standard A=Negative Control Standard B=Cut-Off Control Standard C=Weakly Positive Control Standard D=Positive Control Contains IgG antibodies against Measles,PBS,stabilizers. Enzyme Conjugate IgG Contains anti-human IgG,conjugated to peroxidase,protein-containing buffer,stabilizers. Microtiter Plate Coated with specific antigen. TMB Substrate Solution Contains TMB. TMB Stop Solution 0.5 M H2SO4. Diluent Buffer Contains PBS Buffer,BSA,<0.1% NaN3. Wash Buffer,Concentrate (10x) Contains PBS Buffer,Tween 20. Adhesive Foil For covering of Microtiter Plate during incubation. Plastic Bag Resealable.For dry storage non-used strips.

• 關聯藥證數量: 1

Standard A-D (4 x 2 mL) 1; 10; 40; 150 U/mL. Standard A = Negative Control Standard B = Cut-Off ControlStandard C = Weakly Positive Control Standard D = Positive ControlContains IgG antibodies against Mumps, PBS, stabilizers. Enzyme Conjugate IgG (1 x 14 Ml)Contains anti-human IgG, conjugated to peroxidase, proteincontainingbuffer, stabilizers. Microtiter Plate (1 x 12 x 8) Break apart strips. Coated with specific antigen.TMB Substrate Solution (1 x 14 mL)Contains TMB.TMB Stop Solution (1 x 14 mL)0.5 M H2SO4.Diluent Buffer (1 x 60 mL)Contains PBS Buffer, BSA, < 0.1 % NaN3.Wash Buffer, Concentrate (10x)；(1 x 60 mL)Contains PBS Buffer, Tween 20.Adhesive Foil (2x)Plastic Bag (1x)Resealable.

• 關聯藥證數量: 1

Standard A-D (4 x 2 mL)1;10;35;200 U/mL.Standard A=Negative ControlStandard B=Cut-Off ControlStandard C=Weakly Positive ControlStandard D=Positive ControlContains IgA antibodies against EBV-EA, PBS, stabilizers.Enzyme Conjugate IgA (1 x 14 mL)Contains anti-human IgA, conjugated to peroxidase, protein-containing buffer, stabilizers.Microtiter Plate (1 x 12 x 8)Break apart strips. Coated with specific antigen.TMB Substrate Soltuion (1 x 14 mL)Contains TMB.TMB Stop Solution (1 x 14 mL)0.5 M.H2SO4.Diluent Buffer (1 x 60 mL)Contains PBS Buffer, BSA, <0.1% NaN3.Wash Buffer, Concentrate (10X; 1 x 60 mL)Contains PBS Buffer, Tween 20.Adhesive Foil (2x)For covering of Microtiter Plate during incubation.Plastic Bag (1x)Resealable. For dry storage of non-used strips.

• 關聯藥證數量: 1